ArticleNeonatology2026
NeoCardioLab: A Digital Platform for Neonatal Hemodynamics Education.
Article in Neonatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTargeted neonatal echocardiography and neonatal hemodynamics are increasingly integrated into neonatal intensive care practice. However, access to structured, standardized educational resources and reference tools remains variable across settings. We aimed to describe the global reach, patterns of utilization, and perceived educational value of NeoCardioLab, a digital platform designed for neonatal hemodynamics education and support.
methodsWe conducted a descriptive, mixed-methods study combining retrospective analysis of anonymized usage data from January 2019 to June 2025 with a cross-sectional anonymous online survey conducted from December 2024 to July 2025. Data sources included Google Analytics, App Store Connect, Calconic, and YouTube analytics. Survey responses captured user demographics, utilization patterns, and perceived educational value.
resultsNeoCardioLab reached 98,004 active users across 203 countries between April 2022 and June 2025, with 342,911 page views and 5,861 mobile application downloads. English (75%), Spanish (6%), and French (5%) were the most common user languages from browser settings. Calculator tools were accessed 1,951 times over a 12-month period. Among 128 survey respondents (59% neonatologists), 84% reported increased confidence in neonatal hemodynamics, and perceived usefulness was noted for modules on pulmonary hypertension, congenital heart disease, and congenital diaphragmatic hernia. Reported impacts reflect self-perceived influence on knowledge and practice.
conclusionsOur results suggest that NeoCardioLab has broad global reach and sustained user engagement as an open-access digital platform for neonatal hemodynamics. These findings support a potential role as a complementary educational resource and knowledge translation tool across diverse educational settings in neonatology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.